Accelerating Gene Design, Strain Optimization, and Bioprocess Control for Next-Generation Biomanufacturing We are committed to advancing synthetic biology through the power of AI... BioSynthAI™’s ...

The number of scientific papers that rely on AI has quadrupled, and the scope of problems AI can tackle is expanding by the ...

The massive project will likely take decades to complete, but it has significant oversight built into it to ensure it remains ...

Experts share their insights with The i Paper as the UK becomes home to the first major project looking to write human DNA ...

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million ...